Role of VEGFR‐1 in melanoma acquired resistance to the BRAF inhibitor vemurafenib

Journal of Cellular and Molecular Medicine

Claudia Ceci¹  Lucio Tentori¹  Grazia Graziani¹  Maria Grazia Atzori¹  Maria Luisa Barbaccia¹  Mauro Trapani¹  Federica Ruffini²  Pedro Miguel Lacal²  Stefania D'Atri² 

[1] Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy;Laboratory of Molecular Oncology, IDI‐IRCCS, Rome, Italy;

关键词: angiogenesis;    BRAF inhibitors;    melanoma;    VEGF‐A;    VEGFR‐1;    vemurafenib;   

DOI  :  10.1111/jcmm.14755

来源: Wiley

【 授权许可】

CC BY